Pfizer Inc. Teams With India Brewmaster in Return to $14 Billion Insulin Market

February 24, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Bloomberg -- Biocon Ltd. founder Kiran Mazumdar- Shaw learned the intricacies of enzymes while studying how to make beer. Now Pfizer Inc., the world’s largest drugmaker, is tapping that knowledge to revive its insulin business.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Asia

Pfizer